about
ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitizationDermatologic lasers: three decades of progress.New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug.Wavelength dependence of hematoporphyrin derivative photodynamic treatment effects on rat ears.Photodynamic therapy for malignant tumours of the ampulla of VaterPhotodynamic effect of 5-aminolevulinic acid-loaded nanoparticles on bladder cancer cells: a preliminary investigation.Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates.Homology modeling of human γ-butyric acid transporters and the binding of pro-drugs 5-aminolevulinic acid and methyl aminolevulinic acid used in photodynamic therapy.Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells.Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700-antibody conjugatesLiver ablation therapy.Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice.Apoptotic effects of Photofrin-Diomed 630-PDT on SHEEC human esophageal squamous cancer cells.The future of photodynamic therapy in oncology.Interstitial photodynamic therapy. Clinical experience with diffusing fibres in the treatment of cutaneous and subcutaneous tumours.Strategies for enhanced photodynamic therapy effects.Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.Photosensitized processes in vivo: proposed phototherapeutic applications.Photodynamic Therapy (PDT): PDT Mechanisms.Progress of photodynamic therapy applications in the treatment of musculoskeletal sarcoma (Review).Bridging laboratory and large scale production: preparation and in vitro-evaluation of photosensitizer-loaded nanocarrier devices for targeted drug delivery.Comparative pharmacokinetics of the photosensitizer tin-etiopurpurin in dogs and rats.mTHPC-mediated photodynamic treatment up-regulates the cytokines VEGF and IL-1alpha.Photosensitization with derivatives of haematoporphyrin.Mechanisms of toxicity of photoactivated artificial porphyrins. Role of porphyrin-protein interactions.Synthesis and Biological Analysis of Thiotetra(ethylene glycol) monomethyl Ether-Functionalized Porphyrazines: Cellular Uptake and Toxicity Studies.A test of different photosensitizers for photodynamic treatment of cancer in a murine tumor model.Artifacts in fluorescence emission spectroscopy related to Wood's anomaly.In vitro photosensitizing properties of rhodamine 123 on different human tumor cell lines.Photodynamic therapy of chemically- and ultraviolet B radiation-induced murine skin papillomas by chloroaluminum phthalocyanine tetrasulfonate.Photokinetic and ultrastructural studies on porphyrin photosensitization of HeLa cells.Picosecond fluorescence spectroscopy on incorporation processes of hematoporphyrin derivative into malignant tumor cells in vitro.In vivo fluorescence of tumors after treatment with derivatives of hematoporphyrin.Near infrared light-mediated enhancement of reactive oxygen species generation through electron transfer from graphene oxide to iron hydroxide/oxide.Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.Computer modeling of the complexes of Chlorin e6 with amphiphilic polymers.Use of Cyclodextrins in Anticancer Photodynamic Therapy TreatmentPhotoprotective Effect of the PlantCollaea argentinaagainst Adverse Effects Induced by Photodynamic Therapy
P2860
Q28366258-EF03C1B2-17CF-4C9F-B615-CC4822A97FB2Q31022718-774042D9-8D57-4F1C-AA6A-6C6C9E64E485Q33271133-B5B0747B-CDA4-4E4B-AACC-4E61515C3698Q33873569-4CDB83F9-50CB-4862-BDF6-C467176EDD86Q34408116-4CE1C77D-4D42-4ECD-A9BA-3E9DF5704DACQ34566823-DE6D5DCA-3A4D-4A86-8796-4BF5398A735BQ34664629-F226D3AE-88C3-40F0-B011-A5F07DABC5F5Q34769682-4D508D0F-E7AA-4B69-81B4-51A770ABA928Q35545774-6B51E2F7-B981-4059-9ED8-80AC856E6B76Q35868119-7281FF76-F5A9-4436-B3DA-0BD03BE8C170Q35901545-32E8D45C-F7C3-44A5-81B8-8820CF980E91Q35981418-DFCA3D4A-1ED8-4B69-AA27-2B0A428FD91FQ36028415-9DFBB7EF-AE4C-485F-9213-D235BAED9454Q36317428-BBE9F9EF-63B7-4739-9633-89B8638AD90EQ36429669-D87C37A8-4912-4C75-A769-637E4608C0B6Q36785194-1DD9FB7A-07A7-443A-81DB-AA0FE5C6875AQ36945978-801A38F9-0990-493A-B1A3-8D16965D93EBQ37015155-FB720E0D-CDDD-4DEC-81AD-854F07DE287AQ37969155-79032F69-B954-41A1-8FC0-2A263FAE95ADQ38082984-44A51272-D0B5-4552-9CC2-7795BBF0CBDCQ38247283-0B921F14-795E-47B0-A5B2-96184DC31CE5Q38939439-3C231B1F-6FA0-4AA7-B9D6-27757E1BA05AQ39231959-49ED21C9-5CD4-4343-A493-2ECB007F4605Q39428012-87DE0706-4368-4838-8E6A-1DDE9B17B627Q39478550-516E8F95-53A4-49A6-8B69-6DC82D761F0DQ39696649-91D560D2-B13D-46D2-8993-27393FC51B55Q41918003-A6B1215E-6408-46A5-9683-62AB70349D01Q42204201-3F4D48A5-A337-4D60-9BD3-C73ED5EC0B41Q43855314-A9FC5B19-E977-49A3-85CA-487CDB92A811Q44359577-02EAD2F0-D86B-48F1-A948-8F99B6A8873DQ44729267-8A427546-55B2-4478-8B21-8085E08987DFQ44789037-D65F7A24-26E7-4124-ACD5-DB2992248220Q45249956-3364DC80-7C25-412D-A7EB-C0A4DA0E2FE4Q46198874-A5FD79EE-9B85-4F9D-8F25-94D1887A6E9EQ46435211-F5D01936-AB37-4447-8AD8-68A21AFDD068Q49385229-BE9D5E68-D08E-4CB7-AD74-BE861BC82108Q51092026-13CFDF7F-2435-42C9-8393-EC77E7F329FBQ58692471-A3962CAD-B46B-4CA2-80C9-B486F198670AQ59045103-00B1892B-EA6F-4FC5-BD7A-3F3DEFF564E5
P2860
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Photodynamic therapy (PDT) of malignant tumors.
@en
type
label
Photodynamic therapy (PDT) of malignant tumors.
@en
prefLabel
Photodynamic therapy (PDT) of malignant tumors.
@en
P1476
Photodynamic therapy (PDT) of malignant tumors.
@en
P2093
Dougherty TJ
P304
P356
10.1016/S1040-8428(84)80016-5
P577
1984-01-01T00:00:00Z